VANCOUVER, Canada

and

HOUSTON, Texas

,

Nov. 8, 2021

/PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that

David R. Parkinson

, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings at three upcoming virtual investor conferences.

Peter Virsik

, ESSA’s Chief Operating Officer, and

David S. Wood

, ESSA’s Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Event:

Jefferies London Healthcare Conference


Format (on-demand):

Fireside Chat


Date:

Thursday, November 18, 2021


Time:

8:00 a.m. GMT /

3:00 a.m. ET

Event

:

Piper Sandler

33

^rd

Annual Healthcare Conference


Format (on-demand):

Fireside Chat


Date:

Monday, November 22, 2021


Time:

10 a.m. ET

Event

: Evercore ISI 4

^th

Annual HealthCONx Virtual Conference


Format (on-demand):

Fireside Chat


Date:

Thursday, December 2, 2021


Time:

1:50 p.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA’s website at

www.essapharma.com

. Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.


ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit


www.essapharma.com


and follow us on Twitter under


@ESSAPharma


.

View original content:

https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-three-upcoming-investor-conferences-301418273.html

SOURCE ESSA Pharma Inc